Stay updated on CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Sign up to get notified when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.

Latest updates to the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page
- Check5 days agoChange DetectedNew version v3.3.4 was returned on 2026-01-06, adding core trial sections such as Study Design, Study Status, Outcome Measures, Adverse Events, Baseline Characteristics, and Participant Flow, along with related document sections. This update also replaces the previous revision v3.3.3.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now shows a new 'Results Submitted' entry and revision v3.3.3; the previous 'No Results Posted' note and the 'HHS Vulnerability Disclosure' reference, along with the prior revision v3.3.2, were removed.SummaryDifference0.3%

- Check55 days agoChange DetectedThe study record history shows an addition of revision v3.3.2 and removal of v3.2.0, reflecting maintenance of the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedDeleted a site-wide notice about government funding and operating status, which does not affect the study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check77 days agoChange DetectedThe new screenshot indicates only minor visual adjustments (header, spacing, and table styling) to the Record History page while the version list and data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference12%

Stay in the know with updates to CAR-T Cell Therapy in Heme Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAR-T Cell Therapy in Heme Malignancies Clinical Trial page.